Measure What Matters: How to Ask the Right Questions?
Mette Dyhrberg Founder & CEO, Mymee
Mette Dyhrberg is the founder & CEO of Mymee.
Master your autoimmunity. Reclaim your health.
Pain, fatigue, skin problems, headaches, weight fluctuation, digestive issues: Struggling with autoimmunity can make anyone feel powerless. Mymee figures out the triggers causing your symptoms, so you can take control of your disease and reclaim your health.
Using Mymee is simple. Our intuitive mobile app makes it easy to monitor your symptoms and the factors triggering your autoimmunity issues in real time. A certified Mymee health coach is dedicated to your case, utilizing Mymee’s proven technology and research to identify your triggers and provide support until you are able to gain control of your symptoms and start feeling better.
Mymee defines successful results based on health improvements that are meaningful to you. If you’re experiencing chronic pain and fatigue, then success might mean being able to play soccer with your kids again. If you’re someone who suffers from psoriasis, a meaningful improvement might be clearer skin and some newfound confidence. We know it can be hard to believe that anything can work to help you feel like yourself again. At Mymee, we work hard to make sure that you do.
Source: Sputnik V Official website
Argentina, one of the first nations to utilize Russia’s Sputnik V COVID-19 vaccine broadly, has increased pressure on Moscow over delays in receiving second doses, which are delaying the South American country’s vaccination program, Reuters reports.
The government of Argentina wrote to the Russian government firm RDIF on July 7 to request component 2 doses of the vaccine, which are separate from the first dosage, and to warn that the supply deal was in jeopardy.
Argentina, which has a population of around 45 million people, has given out 22.9 million initial doses of the COVID-19 vaccine, but …
The global pandemic highlighted inefficiencies and inconsistencies in healthcare systems around the world. Even co-founders Mayank Banerjee, Matilde Giglio and Alessandro Ialongo say nowhere is this more evident than in India, especially after the COVID death toll reached 4 million this week.
The Bangalore-based company received a fresh cash infusion of $5 million in seed funding in a round led by Khosla Ventures, with participation from Founders Fund, Lachy Groom and a group of individuals including Palo Alto Networks CEO Nikesh Arora, CRED CEO Kunal Shah, Zerodha founder Nithin Kamath and DST Global partner Tom Stafford.
Even, a healthcare membership company, aims …
According to the Interfax news agency, the Gamma mutation of the novel coronavirus, which was originally discovered in Brazil, has been spotted in modest numbers in Russia, according to the inventor of Russia’s EpiVacCorona vaccine.
Authorities in Russia are reporting an increase in coronavirus infections, which they attribute to the Delta strain and a poor vaccination rate. In the previous 24 hours, Russia reported 24,471 new COVID-19 cases and 796 coronavirus-related fatalities.
The Vector Institute in Siberia produced EpiVacCorona, Russia’s second of four vaccinations to be approved. Russia’s flagship vaccination is Sputnik V, Reuters reports.
The Delta strain is common …
Temasek and Falcon Edge Capital have led a $220 million investment in Indian omni-channel eyewear retailer Lenskart, valuing the Bangalore-based startup at $2.5 billion.
The new investment, which includes primary and secondary transactions, is part of a new round Lenskart unveiled a month ago when it raised $95 million from global investment fund KKR. Bay Capital and Chiratae also participated in the new round.
Peyush Bansal, founder and chief executive of Lenskart, said the profitable startup — which sells eyeglasses and contact lenses online and through about 750 physical retail outlets across the country — has seen a surge in sales of eyewear products in the …
2021 should be a banner year for biotech startups that make smart choices early
Kevin A. O’Connor, Ph.D., is a partner in the Intellectual Property practice group at Neal Gerber Eisenberg.
After a record year for biotech investment in 2020 — during which the industry saw $28.5 billion invested across 1,073 deals — the market for new innovations remains strong. What’s more, these innovations are increasingly coming to market by way of early-stage startups and/or their scientific founders from academia.
In 2018, for instance, U.S. campuses conducted $79 billion worth of sponsored …
Image credit: EPA
The growing incidence of COVID-19 in Russia was caused, in part, by a shift in the prevalent strain of coronavirus, according to Alexander Gorelov, Deputy Director of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing’s Central Research Institute of Epidemiology.
“Because of alterations in different coronavirus strains, the epidemiological situation in Russia and throughout the world remains severe. Each shift in the dominant strain is generally followed by an increase in the incidence. This is the stage we are now at “, he stated.
According to Gorelov, the frequency of coronavirus infection in …
A security lapse at insurance technology startup BackNine exposed hundreds of thousands of insurance applications after one of its cloud servers was left unprotected on the internet.
BackNine might be a company you’re not familiar with, but it might have processed your personal information if you applied for insurance in the past few years. The California-based company builds back-office software to help bigger insurance carriers sell and maintain life and disability insurance policies. It also offers a white-labeled quote web form for smaller or independent financial planners who sell insurance plans through their own websites.
But one of the …
Telehealth platform Eucalyptus raised a $22.3 million Series B round of funding to build a digital health portfolio for primary care in Australia.
NewView Capital led the round with participation from existing investors Blackbird Ventures and W23, and new investor AirTree Ventures. As part of the investment, Ravi Viswanathan, NewView founder and managing partner, will be joining the Eucalyptus board.
The new round gives the Sydney-based company a total of $32.8 million raised since it was founded in 2019 by Tim Doyle, Benny Kleist, Alexey Mitko and Charlie Gearside.
Australia’s healthcare system is a two-payer model, where most of the care is …
Why Employer-Sponsored Health Plans Are Key to Economic Recovery
Employer-sponsored health plans provide high-quality coverage for approximately 180 million people in the United States. Employers’ active engagement in providing health care coverage is a critical underpinning of a successful and sustainable health care system and a booming economy.
The Covid-19 pandemic has brought into focus the inextricable link between the health of the American workforce, the productivity of U.S. businesses, and the vibrancy of the economy. As people begin to safely return to work and life, the nation is poised to re-engage its workforce, regain momentum, and reignite prosperity.